Investigational New Drug CDMO Market size is expected to reach USD 6.8 billion by 2028
Investigational New Drug CDMO Industry Overview The global investigational new drug CDMO market size is expected to reach USD 6.8 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.9% from 2021 to 2028. This is largely due to the increased R&D investments, along with stringent regulations pertaining to IND. Investigational New Drug CDMO Market Segmentation Grand View Research has segmented the global investigational new drug CDMO market based on product, service, end user, and region: Based on the Product Insights, the market is segmented into Small Molecule and Large Molecule The small molecule segment held the largest share of 89.0% in 2020 and is likely to remain dominant over the forecast period. This is largely due to the increasing number of small molecules in development. Small molecules constitute more than 90% of the drugs currently in the market. The large molecule segment is anticipated...